KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib, page-7

  1. Burger88
    69 Posts.
    lightbulb Created with Sketch. 8
    clock Created with Sketch.
    03/11/23
    10:13
    Post #: 70706271
    Dude, the trial is evaluating paxalisib asmonotherapy treatment in patients with relapsed/refractory primary central nervous systemlymphoma (r/r PCNSL). These patients are not ok, aye. They've already been through absolute torture. They are dying.

    They're enrolling because they don't want to die.
    KZA Price at posting: 5.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.